Literature DB >> 15832052

Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children.

Ting-Fan Leung1, Gary W K Wong, Fanny W S Ko, Chung-Yi Li, Edmund Yung, Christopher W K Lam, Tai-Fai Fok.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF), AA isoform of platelet-derived growth factor (PDGF-AA), and epidermal growth factor (EGF) are involved in the pathogenesis of airway inflammation in asthma. These molecules are closely associated with cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-4. This study investigates the relation between childhood asthma and levels of these mediators in exhaled breath condensate (EBC).
METHODS: EBC was collected from asthmatic children and controls using a disposable collection kit, and the concentrations of VEGF, PDGF-AA, EGF, TNF-alpha and IL-4 in EBC were measured using sandwich enzyme immunoassays. Exhaled nitric oxide concentration was measured by a chemiluminescence analyzer.
RESULTS: Thirty-five asthmatic patients aged between 7 and 18 years and 11 controls were recruited. Sixteen patients had intermittent asthma (IA) whereas 19 of them suffered from persistent asthma (PA). A significant correlation was found between IL-4 and TNF-alpha in EBC (rho = 0.374, p = 0.010). PDGF-AA levels in EBC were higher in subjects with diminished FEV1 (p = 0.023) whereas IL-4 concentrations were increased in asthmatics (p = 0.007) as well as subjects with increased plasma total IgE (p = 0.033). Patients with PA receiving high-dose inhaled corticosteroid (ICS) had higher EBC IL-4 concentration than those on low-dose ICS (p = 0.007). Linear regression revealed that PDGF-AA levels in EBC were negatively associated with FEV1 percentage (beta = -0.459, p = 0.006) among the asthmatic patients.
CONCLUSIONS: IL-4 in EBC is increased in childhood asthma, and growth factors are detectable in a significant proportion of these children. Increased PDGF-AA is found in asthmatics with more severe airflow limitation. Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832052     DOI: 10.1159/000085106

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

Review 1.  Are exhaled breath condensates useful in monitoring asthma?

Authors:  Fanny W S Ko; T F Leung; David S C Hui
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

Review 2.  The Importance of Tyrosine Phosphorylation Control of Cellular Signaling Pathways in Respiratory Disease: pY and pY Not.

Authors:  Yael Aschner; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

3.  Epigenetic regulation of DNMT1 gene in mouse model of asthma disease.

Authors:  M Verma; B D Chattopadhyay; B N Paul
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

4.  Nonhuman primate models of asthma.

Authors:  Robert L Coffman; Edith M Hessel
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

5.  Role of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction.

Authors:  Dedmer Schaafsma; Reinoud Gosens; I Sophie T Bos; Herman Meurs; Johan Zaagsma; S Adriaan Nelemans
Journal:  Respir Res       Date:  2005-07-27

Review 6.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

7.  Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Authors:  Marco Fumagalli; Fabio Ferrari; Maurizio Luisetti; Jan Stolk; Pieter S Hiemstra; Daniela Capuano; Simona Viglio; Laura Fregonese; Isa Cerveri; Federica Corana; Carmine Tinelli; Paolo Iadarola
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

8.  Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fanny W S Ko; Ting-Fan Leung; Gary W K Wong; Jenny Ngai; Kin W To; Susanna Ng; David S C Hui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

9.  Effect of Inhaled Budesonide on Interleukin-4 and Interleukin-6 in Exhaled Breath Condensate of Asthmatic Patients.

Authors:  Chun-Hua Chi; Ji-Ping Liao; Yan-Ni Zhao; Xue-Ying Li; Guang-Fa Wang
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

Review 10.  New targets for resolution of airway remodeling in obstructive lung diseases.

Authors:  Ajay P Nayak; Deepak A Deshpande; Raymond B Penn
Journal:  F1000Res       Date:  2018-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.